{"id":"W2910245285","doi":"10.1200/jco.18.00149","title":"Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1716,"is_retracted":false,"has_abstract":true,"ca_institutions":"Kingston General Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Lung cancer; Chemotherapy; Internal medicine; Hazard ratio; Oncology; Tolerability; Clinical endpoint; Chemotherapy regimen; Surgery; Cancer; Confidence interval; Randomized controlled trial; Immunotherapy; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009646003,0.0008754477,0.002036453,0.0004345941,0.0002384221,0.0008546412,0.00130913,0.0007249898,0.004287345],"category_scores_gemma":[0.01055482,0.0004464539,0.004777201,0.0004683204,0.000368158,0.000853802,0.0006990473,0.001731911,0.0003474011],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008649815,"about_ca_system_score_gemma":0.0007954619,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0011063,"about_ca_topic_score_gemma":0.001819319,"domain_scores_codex":[0.993218,0.004897254,0.0003252117,0.0006953342,0.0006463272,0.0002177701],"domain_scores_gemma":[0.9922998,0.003852878,0.001876436,0.001168685,0.0003958466,0.0004063823],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8445023,0.002623045,0.03533982,0.001220603,0.03306606,0.0001811202,0.0001415257,0.007429079,0.005855503,0.000367018,0.004022516,0.06525126],"study_design_scores_gemma":[0.2947522,0.1944775,0.3698161,0.0001885455,0.08654241,0.0007288952,0.000133306,0.02845736,0.0102859,0.001442709,0.01300121,0.0001738866],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9836933,0.003008842,0.004575294,0.0002813852,0.0001118135,0.001277187,0.0047897,0.0001382335,0.002124135],"genre_scores_gemma":[0.990405,0.0003995086,0.002402706,0.000357121,0.00009006479,0.0006263761,0.004423589,0.00003564284,0.001260029],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009646003,"threshold_uncertainty_score":0.05101353,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06235330001325926,"score_gpt":0.4207660967554982,"score_spread":0.3584127967422389,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}